HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$5.09
Day range
$4.87 - $5.16
Year range
$4.87 - $17.80
Market cap
105.65M USD
Avg Volume
644.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 14.61M | -22.84% |
Operating expense | 44.46M | -11.01% |
Net income | -28.82M | -2.55% |
Net profit margin | -197.32 | -32.91% |
Earnings per share | -1.36 | -2.26% |
EBITDA | -29.38M | 3.25% |
Effective tax rate | 1.24% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 248.19M | -32.91% |
Total assets | 376.65M | -18.52% |
Total liabilities | 247.84M | 0.94% |
Total equity | 128.81M | — |
Shares outstanding | 21.19M | — |
Price to book | 0.84 | — |
Return on assets | -19.25% | — |
Return on capital | -20.45% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -28.82M | -2.55% |
Cash from operations | -10.40M | 51.86% |
Cash from investing | 19.07M | 61.14% |
Cash from financing | -7.22M | -31,269.57% |
Net change in cash | 1.46M | 114.89% |
Free cash flow | -18.15M | -80.78% |
About
Founded
1995
Headquarters
Website
Employees
131